Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis; Christopher Baum; Nissim Benvenisty; Gustavo Mostoslavsky; Hideyuki Okano; William L. Stanford; Matthew Porteus; Michel Sadelain

doi:10.1016/j.stem.2010.09.010

Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis, Christopher Baum, Nissim Benvenisty, Gustavo Mostoslavsky, Hideyuki Okano, William L. Stanford, Matthew Porteus, Michel Sadelain

生理学

研究成果: Letter › 査読

19 被引用数 (Scopus)

本文言語	English
ページ（範囲）	429-430
ページ数	2
ジャーナル	Cell stem cell
巻	7
号	4
DOI	https://doi.org/10.1016/j.stem.2010.09.010
出版ステータス	Published - 2010 10月 8

ASJC Scopus subject areas

分子医療
遺伝学
細胞生物学

文献へのアクセス

10.1016/j.stem.2010.09.010

他のファイルとリンク

引用スタイル

@article{050aab29023442d89af1aa73749abe9d,

title = "Benefits of utilizing gene-modified iPSCs for clinical applications",

author = "James Ellis and Christopher Baum and Nissim Benvenisty and Gustavo Mostoslavsky and Hideyuki Okano and Stanford, {William L.} and Matthew Porteus and Michel Sadelain",

year = "2010",

month = oct,

day = "8",

doi = "10.1016/j.stem.2010.09.010",

language = "English",

volume = "7",

pages = "429--430",

journal = "Cell stem cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Benefits of utilizing gene-modified iPSCs for clinical applications

AU - Ellis, James

AU - Baum, Christopher

AU - Benvenisty, Nissim

AU - Mostoslavsky, Gustavo

AU - Okano, Hideyuki

AU - Stanford, William L.

AU - Porteus, Matthew

AU - Sadelain, Michel

PY - 2010/10/8

Y1 - 2010/10/8

UR - http://www.scopus.com/inward/record.url?scp=77957359122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957359122&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2010.09.010

DO - 10.1016/j.stem.2010.09.010

M3 - Letter

C2 - 20887948

AN - SCOPUS:77957359122

SN - 1934-5909

VL - 7

SP - 429

EP - 430

JO - Cell stem cell

JF - Cell stem cell

IS - 4

ER -